Cancer in Special Situations / Population
Here below you will find a list of all the latest content published on this website on the topic of Cancer in Special Situations / Population. The content is published in chronological order.
Areas:
- Cancer in adolescents
- Cancer in young adults
- Cancer in pregnancy
- Cancer in elderly
- AIDS-associated malignancies
- Cancer in patients with comorbidities
- Survivors of Childhood Extracranial Malignancy Who Received Chemotherapy Are Likely to Have Long-Term Neurological Toxicity
- Adolescent and Young Adults with Acute Lymphoblastic Leukaemia Benefit from Treatment in a Paediatric Setting or NCI-Designated Cancer Centre
- Increased Germline and Tumour Mutation Testing Recommended in Adolescent and Young Adults with Cancer
- FDA Approves Everolimus for Tuberous Sclerosis Complex-Associated Partial-Onset Seizures
- Social Network Index Developed to Assess the Support Resources of Adolescent and Young Adult Cancer Survivors
- Web-Based Intervention Increases Physical Activity and QoL in Adolescent Cancer Survivors
- Adherence to Follow-up is Low in Adolescent and Young Adult Cancer Survivors
- CAR T-Cell Therapy Provides High Remission Rate in Paediatric and Young Adult Patients with Relapsed or Refractory B-Cell ALL
- NICE Issues Medtech Innovation Briefing for NGS Panel for Solid Tumours in Children
- FDA Approves Hydroxyurea for Treatment of Paediatric Patients with Sickle Cell Anaemia
- EMA Recommends Extension of Therapeutic Indications for Ipilimumab
- MMR Deficiency Screening is Under-utilised in Young Adult Patients with Colorectal Cancer
- Predictive Model May Determine Risk of Subsequent CNS Tumour in Survivors of Childhood Cancer
- Paediatric, Adolescent, and Young Adult Survivors of Hodgkin’s Disease Face an Elevated Risk of Cardiovascular Disease
- EMA Recommends Extensions of Therapeutic Indications for Nilotinib
- Questionnaire Designed for Adolescent and Young Adults with Cancer Elicits Their Views on Treatment
- Reports on Care Quality for Adolescent and Young Adult Cancer Patients Are Lacking in the Literature
- Written Treatment Summaries Are Crucial to Meeting Needs for Information on Recurrence, Fertility, and Late Treatment Effects in Adolescent and Young Adult Cancer Survivors
- Adolescent and Young Adult Cancer Survivors Are Less Likely to Have HPV-Vaccination than Peers
- FDA Expands Ibrutinib Indications to Chronic GVHD
- FDA Grants Nivolumab Accelerated Approval for MSI-H or dMMR Colorectal Cancer
- FDA Expands Approval of Ipilimumab to Include Paediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma
- Survival After Secondary Primary Malignant Neoplasms Significantly Poorer in Children and AYAs versus Older Patients
- FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease
- Recommendations from the AACR Childhood Cancer Predisposition Workshop